These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7721386)

  • 1. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
    Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ
    Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
    Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
    Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H; Desche P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects.
    Patel V; Rassam SM; Chen HC; Jones M; Kohner EM
    Metabolism; 1998 Dec; 47(12 Suppl 1):28-33. PubMed ID: 9867068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
    Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
    Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
    Pannier BM; Guerin AP; Marchais SJ; London GM
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1074-7. PubMed ID: 11903319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.
    Schiffrin EL; Deng LY; Larochelle P
    Am J Hypertens; 1995 Mar; 8(3):229-36. PubMed ID: 7794571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
    Schiffrin EL; Deng LY; Larochelle P
    Hypertension; 1994 Jan; 23(1):83-91. PubMed ID: 8282334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Blood Press; 1995 Jul; 4(4):241-8. PubMed ID: 7496564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients.
    Girerd X; Giannattasio C; Moulin C; Safar M; Mancia G; Laurent S
    J Am Coll Cardiol; 1998 Apr; 31(5):1064-73. PubMed ID: 9562008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor.
    Schiffrin EL
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S13-8. PubMed ID: 8723394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril and reference antihypertensives.
    Thurston H
    S Afr Med J; 1991 Oct; Suppl():10-4; discussion 15. PubMed ID: 1925813
    [No Abstract]   [Full Text] [Related]  

  • 17. First-line treatment in hypertension. Role of perindopril.
    Zanchetti A
    Drugs; 1990; 39 Suppl 1():71-5. PubMed ID: 2407495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.
    Schiffrin EL; Deng LY
    Hypertension; 1995 Apr; 25(4 Pt 2):699-703. PubMed ID: 7721419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent effects of perindopril on blood pressure and small-artery structure.
    Thybo NK; Korsgaard N; Eriksen S; Christensen KL; Mulvany MJ
    Hypertension; 1994 May; 23(5):659-66. PubMed ID: 8175177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.